Andreas Ohm,Klaus Benke,Hanna Tinel,Joachim Hütter
申请号：
US11922745
公开号：
US08153160B2
申请日:
2006.06.29
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to a pharmaceutical dosage form comprising an active ingredient combination of nifedipine and/or nisoldipine and at least one angiotensin II antagonist, characterized in that the active ingredient combination undergoes controlled (modified) release in the body, and to processes for the production thereof, to the use thereof as pharmaceuticals, to the use thereof for the prophylaxis, secondary prophylaxis and/or treatment of disorders, and to the use thereof for manufacturing a pharmaceutical for the prophylaxis, secondary prophylaxis and/or treatment of disorders.
